View in EDS

Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer.

Saved in:
Bibliographic Details
Title: Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer.
Authors: Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alban TJ; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., Haddad RI; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Saul M; Pfizer, La Jolla, CA, USA., Makarov V; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., Zhu Y; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cohen EEW; Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USA., Ferris RL; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Chang PM; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan., Lin JC; Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan., Psyrri A; National Kapodistrian University of Athens, Athens, Greece., Parthasarathy PB; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., Novaj A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gawali M; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., Hoen D; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., Hamilton P; Pfizer, La Jolla, CA, USA., Silver NL; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., Juric I; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., Chawla D; Pfizer, La Jolla, CA, USA., Gradissimo A; Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ko J; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., McGrail DJ; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., Davis CB; Pfizer, La Jolla, CA, USA. craig.davis@pfizer.com., Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. leen2@mskcc.org., Chan TA; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA. chant2@ccf.org.; National Center for Regenerative Medicine, Cleveland, OH, USA. chant2@ccf.org.
Source: Nature cancer [Nat Cancer] 2026 Jan; Vol. 7 (1), pp. 98-115. Date of Electronic Publication: 2026 Jan 02.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41482527
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Riaz+N%22">Riaz N</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Alban+TJ%22">Alban TJ</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Haddad+RI%22">Haddad RI</searchLink>; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Saul+M%22">Saul M</searchLink>; Pfizer, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Makarov+V%22">Makarov V</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+Y%22">Zhu Y</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+EEW%22">Cohen EEW</searchLink>; Moores Cancer Center, University of California San Diego Health, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ferris+RL%22">Ferris RL</searchLink>; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Chang+PM%22">Chang PM</searchLink>; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+JC%22">Lin JC</searchLink>; Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan.<br /><searchLink fieldCode="AU" term="%22Psyrri+A%22">Psyrri A</searchLink>; National Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Parthasarathy+PB%22">Parthasarathy PB</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Novaj+A%22">Novaj A</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gawali+M%22">Gawali M</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Hoen+D%22">Hoen D</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+P%22">Hamilton P</searchLink>; Pfizer, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Silver+NL%22">Silver NL</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Juric+I%22">Juric I</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Chawla+D%22">Chawla D</searchLink>; Pfizer, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gradissimo+A%22">Gradissimo A</searchLink>; Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ko+J%22">Ko J</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22McGrail+DJ%22">McGrail DJ</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Davis+CB%22">Davis CB</searchLink>; Pfizer, La Jolla, CA, USA. craig.davis@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Lee+NY%22">Lee NY</searchLink>; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. leen2@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Chan+TA%22">Chan TA</searchLink>; Department of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA. chant2@ccf.org.; National Center for Regenerative Medicine, Cleveland, OH, USA. chant2@ccf.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2026 Jan; Vol. 7 (1), pp. 98-115. <i>Date of Electronic Publication: </i>2026 Jan 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41482527
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s43018-025-01068-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 98
    Titles:
      – TitleFull: Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Riaz N
      – PersonEntity:
          Name:
            NameFull: Alban TJ
      – PersonEntity:
          Name:
            NameFull: Haddad RI
      – PersonEntity:
          Name:
            NameFull: Saul M
      – PersonEntity:
          Name:
            NameFull: Makarov V
      – PersonEntity:
          Name:
            NameFull: Zhu Y
      – PersonEntity:
          Name:
            NameFull: Cohen EEW
      – PersonEntity:
          Name:
            NameFull: Ferris RL
      – PersonEntity:
          Name:
            NameFull: Chang PM
      – PersonEntity:
          Name:
            NameFull: Lin JC
      – PersonEntity:
          Name:
            NameFull: Psyrri A
      – PersonEntity:
          Name:
            NameFull: Parthasarathy PB
      – PersonEntity:
          Name:
            NameFull: Novaj A
      – PersonEntity:
          Name:
            NameFull: Gawali M
      – PersonEntity:
          Name:
            NameFull: Hoen D
      – PersonEntity:
          Name:
            NameFull: Hamilton P
      – PersonEntity:
          Name:
            NameFull: Silver NL
      – PersonEntity:
          Name:
            NameFull: Juric I
      – PersonEntity:
          Name:
            NameFull: Chawla D
      – PersonEntity:
          Name:
            NameFull: Gradissimo A
      – PersonEntity:
          Name:
            NameFull: Ko J
      – PersonEntity:
          Name:
            NameFull: McGrail DJ
      – PersonEntity:
          Name:
            NameFull: Davis CB
      – PersonEntity:
          Name:
            NameFull: Lee NY
      – PersonEntity:
          Name:
            NameFull: Chan TA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2662-1347
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature cancer
              Type: main
ResultId 1